Drug Type Chemical drugs |
Synonyms |
Target |
Action agonists |
Mechanism Kv3.1 agonists(Voltage-gated potassium channel subunit Kv3.1 agonists), Kv3.2 agonists(potassium voltage-gated channel subfamily C member 2 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cognition Disorders | Preclinical | Australia | 01 Nov 2022 | |
| Social Behavior Disorders | Preclinical | Australia | 01 Nov 2022 |





